The US Food and Drug Administration (FDA) recently issued warning letters to popular sunscreen brands, Supergoop! and Vacation, regarding their mousse sunscreen products. This action was taken as the mousse format is not currently approved under US sunscreen regulations, leading to concerns about its effectiveness. The FDA highlighted the potential inefficacy of sunscreen products in mousse form and sent out five warning letters to companies marketing such products.
Supergoop! received a warning letter regarding its PLAY SPF Body Mousse, while Vacation was issued a similar notice for two of its products: Classic Whip Broad Spectrum SPF 30 Sunscreen Mousse and Classic Whip Glow Broad Spectrum SPF 30 Shimmer Sunscreen Mousse. The FDA mentioned that approved sunscreen formats in the US include oil, lotion, cream, gel, butter, paste, ointment, stick, spray, and powder, but do not cover sunscreen in a mousse dosage form.
Furthermore, Vacation’s use of metal canisters resembling those used for edible whipped cream was deemed misleading and potentially risky for consumers, posing a risk of accidental ingestion. Alongside Supergoop! and Vacation, warning letters were also sent to K & Care Organics, Kalani Sunwear, and Fallene Cosmeceutical regarding their mousse sunscreen products. These warnings emphasize the strict requirements for over-the-counter (OTC) drugs like sunscreens in the US, which involve stringent regulations on marketing and labeling.
In response to the FDA warnings, Supergoop! reiterated its commitment to product efficacy and safety standards, clarifying that the FDA’s concerns were related to product labeling rather than safety, effectiveness, or the formula itself. Kalani Sunwear also provided a statement indicating that the FDA warning was based on regulatory classification requirements and not on the safety or efficacy of their Sun Mousse SPF 50 product developed to European standards.
The companies have been given a 15-day deadline to respond to the FDA, outlining corrective actions taken to address violations and prevent future occurrences. This move by the FDA underscores the need for compliance with US regulations for sunscreen products to ensure consumer safety and efficacy. As the sunscreen industry continues to evolve, with new innovations and regulatory updates, it is crucial for brands to align with the latest guidelines to maintain consumer trust and product quality.
Key Takeaways:
– FDA issued warning letters to Supergoop! and Vacation regarding their mousse sunscreen products due to non-compliance with US regulations.
– The warning highlighted concerns about the efficacy of sunscreen products in mousse form and the misleading packaging practices of some brands.
– Companies must respond to FDA warnings within 15 days, demonstrating corrective actions taken to address violations and prevent future occurrences.
– Compliance with stringent sunscreen regulations is essential for ensuring consumer safety and maintaining product quality in the evolving sunscreen industry.
Tags: formulation
Read more on cosmeticsbusiness.com